These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38735709)

  • 1. The Association between PDE5 Inhibitors and Aneurysm/Arterial Dissection:A Pharmacovigilance Study Using WHO Safety Database.
    Miyata K; Izawa-Ishizawa Y; Niimura T; Hamano H; Aizawa F; Yagi K; Kawada K; Zamami Y; Goda M; Ishizawa K
    J Med Invest; 2024; 71(1.2):134-140. PubMed ID: 38735709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study.
    Chen G; Zhang L; Zhao ST; Huang H; Fu Z
    Expert Opin Drug Saf; 2024 Jul; 23(7):877-884. PubMed ID: 38739482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database.
    Lui JL; Shaw NM; Abbasi B; Hakam N; Breyer BN
    Andrology; 2023 Oct; 11(7):1408-1417. PubMed ID: 36905319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database.
    Cutroneo PM; Arzenton E; Furci F; Scapini F; Bulzomì M; Luxi N; Caminati M; Senna G; Moretti U; Trifirò G
    BioDrugs; 2024 May; 38(3):425-448. PubMed ID: 38489062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database.
    Ado Moumouni AN; Robin P; Hillaire-Buys D; Faillie JL
    Fundam Clin Pharmacol; 2018 Apr; 32(2):216-226. PubMed ID: 29144574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride.
    Nguyen DD; Marchese M; Cone EB; Paciotti M; Basaria S; Bhojani N; Trinh QD
    JAMA Dermatol; 2021 Jan; 157(1):35-42. PubMed ID: 33175100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system.
    Meng L; Huang J; Jia Y; Huang H; Qiu F; Sun S
    Int J Clin Pract; 2019 May; 73(5):e13331. PubMed ID: 30809871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection-A pharmacovigilance analysis.
    Dörks M; Jobski K; Herget-Rosenthal S; Hoffmann F; Douros A
    Pharmacol Res Perspect; 2021 Feb; 9(1):e00707. PubMed ID: 33421342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO-VigiBase.
    Ha M; Yoon D; Lee CY; Lee M; Kim YW; Lee JM; Shin JY
    J Pineal Res; 2024 Mar; 76(2):e12949. PubMed ID: 38528668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase).
    Niimura T; Miyata K; Hamano H; Nounin Y; Unten H; Yoshino M; Mitsuboshi S; Aizawa F; Yagi K; Koyama T; Goda M; Kanda Y; Izawa-Ishizawa Y; Zamami Y; Ishizawa K
    Drug Saf; 2023 Jun; 46(6):545-552. PubMed ID: 37106270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
    Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Safety Profile of BRAF and MEK Inhibitors: Data from the World Health Organization Pharmacovigilance Database.
    Mettler C; Monnet D; Kramkimel N; Tréluyer JM; Mouthon L; Brézin A; Dupin N; Valnet-Rabier MB; Chouchana L; Terrier B
    Ophthalmology; 2021 Dec; 128(12):1748-1755. PubMed ID: 34000304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic study.
    Cornet L; Khouri C; Roustit M; Guignabert C; Chaumais MC; Humbert M; Revol B; Despas F; Montani D; Cracowski JL
    Eur Respir J; 2019 May; 53(5):. PubMed ID: 30846469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.
    Hlavaty A; Roustit M; Montani D; Chaumais MC; Guignabert C; Humbert M; Cracowski JL; Khouri C
    Br J Clin Pharmacol; 2022 Dec; 88(12):5227-5237. PubMed ID: 35679331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports.
    Wakao R; Taavola H; Sandberg L; Iwasa E; Soejima S; Chandler R; Norén GN
    Drug Saf; 2019 Dec; 42(12):1487-1498. PubMed ID: 31559542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirst and drugs: A study in the World Health Organization's pharmacovigilance database.
    Montastruc JL
    Br J Clin Pharmacol; 2024 Jun; 90(6):1525-1528. PubMed ID: 38627211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aneurysm and Artery Dissection Following the Use of Vascular Endothelial Growth Factor Inhibitor: A Real-World Analysis Using a Spontaneous Reporting System.
    Wang S; Chen M; Zhang X; Zhang L; Jia M; Shen Z; Wang J; Zhao B; Gong Y; Gong J
    J Am Heart Assoc; 2021 Dec; 10(23):e020844. PubMed ID: 34845918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase
    Noseda R; Bedussi F; Gobbi C; Ceschi A; Zecca C
    J Headache Pain; 2024 Jan; 25(1):10. PubMed ID: 38243189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature.
    Cheng C; Nguyen MN; Nayernama A; Jones SC; Brave M; Agrawal S; Amiri-Kordestani L; Woronow D
    Vasc Med; 2021 Oct; 26(5):526-534. PubMed ID: 33840328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.